Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 182,723 | 197,265 | 203,889 | 213,643 | 278,622 |
| Cost of Goods | 124,709 | 129,050 | 134,619 | 144,274 | 168,517 |
| Gross Profit | 58,014 | 68,215 | 69,270 | 69,369 | 110,105 |
| Operating Expenses | 35,081 | 21,447 | 21,996 | 26,926 | 20,172 |
| Operating Income | 23,642 | 46,818 | 47,893 | 42,717 | 90,450 |
| Interest Expense | 3,390 | 3,471 | 3,116 | 2,403 | 2,882 |
| Pre-tax Income | 20,252 | 43,347 | 44,777 | 40,314 | 87,568 |
| Income Tax | 4,658 | 9,753 | 10,075 | 9,272 | 20,841 |
| Net Income Continuous | 15,594 | 33,594 | 34,702 | 31,042 | 66,727 |
| Minority Interests | 176 | 190 | 76 | -357 | 537 |
| Net Income | $15,418 | $33,404 | $34,626 | $31,399 | $66,190 |
| EPS Basic Total Ops | 0.37 | 0.79 | 0.81 | 0.72 | 1.50 |
| EPS Basic Continuous Ops | 0.37 | 0.79 | 0.81 | 0.72 | 1.52 |
| EPS Diluted Total Ops | 0.37 | 0.78 | 0.81 | 0.72 | 1.50 |
| EPS Diluted Continuous Ops | 0.37 | 0.79 | 0.81 | 0.71 | 1.52 |
| EBITDA(a) | $30,693 | $53,728 | $54,823 | $49,283 | $97,350 |